Open AccessHypokalemia-Induced Rhabdomyolysis From Budesonide Therapy in Crohn's Disease
Author(s) -
Ramy Mansour,
Pujyitha Mandiga,
Derek Thigpin
Publication year - 2019
Publication title -
acg case reports journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 4
ISSN - 2326-3253
DOI - 10.14309/crj.0000000000000201
Subject(s) - medicine , budesonide , hypokalemia , rhabdomyolysis , discontinuation , muscle weakness , crohn's disease , gastroenterology , disease , corticosteroid
We present a 71-year-old white man with active ileocolonic Crohn's disease, recently started on budesonide therapy, who presented with extreme weakness and muscle aches. He was diagnosed with hypokalemia-induced rhabdomyolysis, 3 weeks after starting budesonide therapy. His symptoms and laboratory values improved with budesonide discontinuation and appropriate fluid and electrolyte replacement. This is only the second case of hypokalemia-induced rhabdomyolysis secondary to budesonide.